Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Cancer Prev Res (Phila). 2010 Dec 16;4(2):230–237. doi: 10.1158/1940-6207.CAPR-10-0249

Figure 5.

Figure 5

STAT3 levels in 4-NQO-induced dysplasia. Photomicrographs of the dysplastic lesions with the median immunostain score for each group, occurring in tongues of animals from the vehicle (A), erlotinib (B) and guggulipid (C)-treated groups stained for STAT3. D. Graphical description of immunostain scores for each group (p= 0.11 for vehicle versus erlotinib and p = 0.41 for vehicle versus guggulipid).